Literature DB >> 27733709

The first 30 months of the MindSpot Clinic: Evaluation of a national e-mental health service against project objectives.

Nickolai Titov1,2,3, Blake F Dear1,2, Lauren G Staples1,2, James Bennett-Levy4, Britt Klein5, Ronald M Rapee1, Gerhard Andersson6, Carol Purtell2, Greg Bezuidenhout2, Olav B Nielssen2.   

Abstract

OBJECTIVE: The MindSpot Clinic provides online mental health services to Australian adults with anxiety and depression. This paper describes users of MindSpot between January 2013 and June 2015. Outcomes are considered against three key objectives: improving access to mental health services, improving public awareness of how to access services and providing evidence-based treatments.
METHOD: Website traffic data were examined to determine patterns of use. Demographic characteristics, past service utilisation and reasons for contacting MindSpot were analysed. Outcomes for patients enrolled in a MindSpot treatment course were also analysed. Primary outcomes were scores on the 9-Item Patient Health Questionnaire, Generalised Anxiety Disorder 7-Item, Yale-Brown Obsessive Compulsive Scale and Post-Traumatic Stress Disorder Checklist-Civilian Version, administered at assessment, post-treatment and 3-month follow-up.
RESULTS: The website was visited by almost 500,000 Australians, of which 33,990 adults started assessments, and 25,469 people completed assessment and were eligible for analysis. Mean age was 36.4 years (standard deviation = 13.3 years; range = 18-94 years), and 72% were female. The proportion living in rural or remote regions and who identified as Aboriginal and Torres Strait Islander closely matched national statistics. The majority (82%) reported that they were not currently in contact with mental health services. Most patients sought an assessment, information about treatment options, or referral to another service, and only 24% of those completing an assessment commenced a MindSpot treatment course. Of these, large clinical effects ( d: 0.7-2.4; average symptom reductions: 25.5% to 61.6%) were found from assessment to follow-up on all outcome measures. Deterioration ranged from 1.0% to 4.3%.
CONCLUSION: Based on the number of website visits, completed assessments and treatment outcomes, MindSpot achieved its three programme objectives. This model of service provision has considerable value as a complement to existing services, and is proving particularly important for improving access for people not using existing services.

Entities:  

Keywords:  Internet treatment; anxiety; cognitive behaviour therapy; depression; service implementation

Mesh:

Year:  2016        PMID: 27733709     DOI: 10.1177/0004867416671598

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  43 in total

Review 1.  Digital apothecaries: a vision for making health care interventions accessible worldwide.

Authors:  Ricardo F Muñoz; Denise A Chavira; Joseph A Himle; Kelly Koerner; Jordana Muroff; Julia Reynolds; Raphael D Rose; Josef I Ruzek; Bethany A Teachman; Stephen M Schueller
Journal:  Mhealth       Date:  2018-06-04

2.  Summary of Key Issues Raised in the Technology for Early Awareness of Addiction and Mental Illness (TEAAM-I) Meeting.

Authors:  Amit Baumel; Justin Baker; Michael L Birnbaum; Helen Christensen; Munmun De Choudhury; David C Mohr; Fred Muench; Danielle Schlosser; Nick Titov; John M Kane
Journal:  Psychiatr Serv       Date:  2018-01-16       Impact factor: 3.084

3.  Digital Trajectories to Care in First-Episode Psychosis.

Authors:  Michael L Birnbaum; Asra F Rizvi; Keren Faber; Jean Addington; Christoph U Correll; Carla Gerber; Adrienne C Lahti; Rachel L Loewy; Daniel H Mathalon; Leigh Anne Nelson; Aristotle N Voineskos; Elaine F Walker; Elise Ward; John M Kane
Journal:  Psychiatr Serv       Date:  2018-09-26       Impact factor: 3.084

4.  Initial Outcomes of Transdiagnostic Internet-Delivered Cognitive Behavioral Therapy Tailored to Public Safety Personnel: Longitudinal Observational Study.

Authors:  Heather D Hadjistavropoulos; Hugh C McCall; David L Thiessen; Ziyin Huang; R Nicholas Carleton; Blake F Dear; Nickolai Titov
Journal:  J Med Internet Res       Date:  2021-05-05       Impact factor: 5.428

5.  Banbury Forum Consensus Statement on the Path Forward for Digital Mental Health Treatment.

Authors:  David C Mohr; Francisca Azocar; Andrew Bertagnolli; Tanzeem Choudhury; Paul Chrisp; Richard Frank; Henry Harbin; Trina Histon; Debra Kaysen; Camille Nebeker; Derek Richards; Stephen M Schueller; Nickolai Titov; John Torous; Patricia A Areán
Journal:  Psychiatr Serv       Date:  2021-01-20       Impact factor: 4.157

6.  Five-year observational study of Internet-delivered cognitive behavioural pain management when offered as routine care by an online therapy clinic.

Authors:  Heather D Hadjistavropoulos; Vanessa Peynenburg; David Thiessen; Luke H Schneider; Marcie Nugent; Andrew Wilhelms; Eyal Karin; Nickolai Titov; Blake F Dear
Journal:  Eur J Pain       Date:  2021-10-12       Impact factor: 3.651

7.  Diversity in eMental Health Practice: An Exploratory Qualitative Study of Aboriginal and Torres Strait Islander Service Providers.

Authors:  Jennifer Bird; Darlene Rotumah; James Bennett-Levy; Judy Singer
Journal:  JMIR Ment Health       Date:  2017-05-29

8.  Translating E-Mental Health Into Practice: What Are the Barriers and Enablers to E-Mental Health Implementation by Aboriginal and Torres Strait Islander Health Professionals?

Authors:  James Bennett-Levy; Judy Singer; Simon DuBois; Kelly Hyde
Journal:  J Med Internet Res       Date:  2017-01-11       Impact factor: 5.428

9.  Internet interventions: Past, present and future.

Authors:  Gerhard Andersson
Journal:  Internet Interv       Date:  2018-04-06

10.  Behavioral Activation and Depression Symptomatology: Longitudinal Assessment of Linguistic Indicators in Text-Based Therapy Sessions.

Authors:  Hannah A Burkhardt; George S Alexopoulos; Michael D Pullmann; Thomas D Hull; Patricia A Areán; Trevor Cohen
Journal:  J Med Internet Res       Date:  2021-07-14       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.